These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24423711)

  • 1. Emergence of carbapenem-resistant Klebsiella spp. infections in a Turkish university hospital: epidemiology and risk factors.
    Dizbay M; Guzel Tunccan O; Karasahin O; Aktas F
    J Infect Dev Ctries; 2014 Jan; 8(1):44-9. PubMed ID: 24423711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].
    Us E; Tekeli A; Arikan Akan O; Dolapci I; Sahin F; Karahan ZC
    Mikrobiyol Bul; 2010 Jan; 44(1):1-10. PubMed ID: 20455393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and epidemiological analysis of nosocomial carbapenem-resistant Klebsiella spp. using repetitive extragenic palindromic-polymerase chain reaction and matrix-assisted laser desorption/ionization-time of flight.
    Treviño M; Navarro D; Barbeito G; García-Riestra C; Crespo C; Regueiro BJ
    Microb Drug Resist; 2011 Sep; 17(3):433-42. PubMed ID: 21568752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options.
    Kontopidou F; Giamarellou H; Katerelos P; Maragos A; Kioumis I; Trikka-Graphakos E; Valakis C; Maltezou HC;
    Clin Microbiol Infect; 2014 Feb; 20(2):O117-23. PubMed ID: 23992130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.
    Maltezou HC; Kontopidou F; Katerelos P; Daikos G; Roilides E; Theodoridou M
    Pediatr Infect Dis J; 2013 Apr; 32(4):e151-4. PubMed ID: 23249908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
    Hu Y; Ping Y; Li L; Xu H; Yan X; Dai H
    J Infect Dev Ctries; 2016 Mar; 10(3):208-13. PubMed ID: 27031451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
    Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy.
    Corbellini S; Caccuri F; Gelmi M; De Francesco MA; Fiorentini S; Caruso A; Giagulli C
    New Microbiol; 2014 Apr; 37(2):177-83. PubMed ID: 24858644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.
    Vitkauskiene A; Dambrauskiene A; Cerniauskiene K; Rimdeika R; Sakalauskas R
    Scand J Infect Dis; 2013 Mar; 45(3):213-8. PubMed ID: 23113773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013.
    Zarakolu P; Eser OK; Aladag E; Al-Zahrani IA; Day KM; Atmaca O; Boral B; Cakir B; Perry JD; Akova M
    Diagn Microbiol Infect Dis; 2016 Aug; 85(4):466-70. PubMed ID: 27306118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Sao Paulo, Brazil.
    Pereira GH; Garcia DO; Mostardeiro M; Ogassavara CT; Levin AS
    J Hosp Infect; 2011 Oct; 79(2):182-3. PubMed ID: 21798628
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.
    Giannella M; Trecarichi EM; De Rosa FG; Del Bono V; Bassetti M; Lewis RE; Losito AR; Corcione S; Saffioti C; Bartoletti M; Maiuro G; Cardellino CS; Tedeschi S; Cauda R; Viscoli C; Viale P; Tumbarello M
    Clin Microbiol Infect; 2014 Dec; 20(12):1357-62. PubMed ID: 24980276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
    González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
    Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.
    Wener KM; Schechner V; Gold HS; Wright SB; Carmeli Y
    Antimicrob Agents Chemother; 2010 May; 54(5):2010-6. PubMed ID: 20211888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
    Oliveira MS; Prado GV; Costa SF; Grinbaum RS; Levin AS
    J Antimicrob Chemother; 2008 Jun; 61(6):1369-75. PubMed ID: 18367459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
    Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.